Stocks and InvestingStocks and Investing
Wed, April 11, 2018
Tue, April 10, 2018
Mon, April 9, 2018
Fri, April 6, 2018
Thu, April 5, 2018
Wed, April 4, 2018
Tue, April 3, 2018
Mon, April 2, 2018
Thu, March 29, 2018

Arlinda Lee Maintained (AKTX) at Strong Buy with Decreased Target to $160 on, Mar 29th, 2018


Published on 2024-10-26 04:10:45 - WOPRAI, Arlinda Lee
  Print publication without navigation


Arlinda Lee of Canaccord Genuity, Maintained "Akari Therapeutics, Plc" (AKTX) at Strong Buy with Decreased Target from $300 to $160 on, Mar 29th, 2018.

Arlinda has made no other calls on AKTX in the last 4 months.



There is 1 other peer that has a rating on AKTX. Out of the 1 peers that are also analyzing AKTX, all agrees with Arlinda's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Madhu Kumar of "B. Riley Securities" Initiated at Hold and Held Target at $60 on, Thursday, February 8th, 2018